Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection

Emerg Microbes Infect. 2022 Dec;11(1):786-789. doi: 10.1080/22221751.2022.2045877.

Authors

A Mancon¹, A Rizzo¹, D Mileto¹, S Grosso¹, A Foschi², M Cutrera¹, A Capetti², I Faggion², A Anselmo³, A Monte³, S Fillo³, G Rizzardini², M R Gismondo^{1

4}, V Micheli¹

Affiliations

¹ Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco - University of Milan, Milan, Italy.
² Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.
³ Scientific Department Army Medical Center, Rome, Italy.
⁴ L. Sacco Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

No abstract available

Keywords: IFN-γ; SARS-CoV-2; immunosuppression; seroconversion; viral evolution.

Publication types

Letter

MeSH terms

Antibodies, Viral
COVID-19*
Humans
Immunocompromised Host
SARS-CoV-2
Seroconversion

Substances

Antibodies, Viral